NL-OMON40299招募中不适用
ong-term follow-up of the prospective and comparative study of the performance of tension free vaginal mesh (ProliftTM) versus conventional pelvic organ prolapse surgery in recurrent prolapse - VROUW 1 follow-up
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 190
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •a. The study population is already selected and randomisation and surgery already have taken place (Withagen 2011, Vrouw 1 trial).
- •b. Subject is willing to return for follow-up evaluation and/or QoL questionnaires completion at 7 years and/or 10 years after surgery.
排除标准
- •a. Subject is unwilling or unable to complete questionnaire and/or return for evaluation
- •b. Presence or treatment of malignancy in the pelvis / lower abdomen
研究者
相似试验
招募中
不适用
ong term follow-up protocol of prospective cohort study on bone mineral density changes in the stage 1 or 2 gastric cancer patients after gastrectomygastric cancerJPRN-UMIN000043647Kindai University170
招募中
1 期
ong-term Follow-up Study for Participants Previously Treated with Ciltacabtagene AutoleucelMedDRA version: 21.0Level: LLTClassification code: 10028228Term: Multiple myeloma Class: 10029104Multiple MyelomaCTIS2023-505530-10-00Janssen - Cilag International365
进行中（未招募）
1 期
ong-term Follow-up Study for Participants Previously Treated with Ciltacabtagene AutoleucelMultiple MyelomaEUCTR2020-005521-84-ESJanssen-Cilag International NV400
尚未招募
4 期
ong-term Follow-up Study for Participants Previously Treated with Ciltacabtagene Autoleucelplasma cell myeloma10040778Multiple MyelomaNL-OMON53393Janssen-Cilag International NV6
进行中（未招募）
1 期
ong-term Follow-up Study for Participants Previously Treated with Ciltacabtagene AutoleucelMedDRA version: 21.0Level: LLTClassification code 10028228Term: Multiple myelomaSystem Organ Class: 100000004864Multiple MyelomaEUCTR2020-005521-84-NLJanssen-Cilag International NV400